Location History:
- Ashigarakami-gun, JP (2017)
- Kanagawa, JP (2020)
Company Filing History:
Years Active: 2017-2020
Title: **Innovative Contributions of Kyoko Senga**
Introduction
Kyoko Senga, a prominent inventor based in Kanagawa, Japan, has made significant advancements in pharmaceutical compositions. With a total of four patents to her name, she exemplifies dedication and innovation in her field.
Latest Patents
Senga's latest patents focus on unique pharmaceutical compositions that enhance the efficacy of fulvestrant, a medication used primarily in breast cancer treatment. The first patent details a composition that contains fulvestrant in amounts equal to or greater than 8% by mass. It specifies an aqueous solvent and a pharmaceutically acceptable nonaqueous carrier, detailing specific ranges for components such as ethanol, polyhydric alcohols, benzyl alcohol, and benzyl benzoate. Her second patent similarly captures a composition comprising fulvestrant and multiple other compounds, specifying the allowed mass percentages for each ingredient, ensuring safety and effectiveness.
Career Highlights
Kyoko Senga has committed her career to pharmaceutical innovation, working at Fujifilm Corporation, a company known for its technological advancements and commitment to healthcare. Her work reflects the intersection of science and practical application, highlighting her role in developing vital medications.
Collaborations
Senga collaborates with fellow researchers and innovators, including Hiroki Tanisaka and Takeshi Matsumoto. Their joint efforts embody teamwork in scientific discovery, showcasing how collaborative environments can lead to significant breakthroughs in pharmaceutical solutions.
Conclusion
With her proven track record of patents and contributions to pharmaceutical development, Kyoko Senga continues to inspire aspiring inventors and contribute to advancements in healthcare. Her innovative minds work towards specific, effective solutions that enhance the lives of many, marking her as a key figure in her industry.